Revolve Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Revolve Wealth Partners's ABBV Position: Q2 2026 in Review
Revolve Wealth Partners increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $38.1K and bringing the position to 7,998 shares worth $2.01M. The position accounts for 0.21% of the portfolio, ranked #68.
Revolve Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Revolve Wealth Partners held 7,998 shares of AbbVie worth $2.01M as of Q2 2026.
- Revolve Wealth Partners bought 177 AbbVie shares in Q2 2026, an estimated $38.1K.
- AbbVie made up 0.21% of Revolve Wealth Partners's portfolio in Q2 2026, its #68 holding.
- Revolve Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.